Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-29 | Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute. |
| 2015-04-29 | Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute. |
| 2016-04-13 | Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute. |
| 2017-04-12 | Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute. |
| 2018-02-28 | Ramesh Kumar, Ph.D.(7) 292,209 1.6% Includes (i) 37,510 shares of common stock held by the Ramesh Kumar 2012 Trust and (ii) 189,982 shares of common stock subject to outstanding warrants and options that are exercisable within 60 days of February 16, 2018. |
| 2018-05-17 | Ramesh Kumar, Ph.D. is listed as President and Chief Executive Officer and a director but no software-related skills or technical background are mentioned. |
| 2018-06-08 | Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute. |
Data sourced from SEC filings. Last updated: 2026-02-03